Innoviva (INVA) Stock Price, Quote, News & History | Benzinga

Innoviva (INVA) Stock Price, Quote, News & History

INVANASDAQ

Logo brought to you by Benzinga Data

Trade with Public

Trade with Public

$20.00

0.251.27%

At close: Jan 30, 4:00 PM EST

$20.02

0.020.10%

After Hours: 5:31 PM EST

Overview

News Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$19.69

Close

$20.00

Volume / Avg.

836.86K / 830.41K

Day Range

$19.58 - $20.15

52 Wk Range

16.52 - 22.76

Market Cap

$1.50B

P/E Ratio

11.90

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

10.46%

Days to Cover

5.57

Recent Innoviva Inc News

This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday

Avi Kapoor

This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

201.66M

Investing Cash Flow (TTM)

1.38M

Financing Cash Flow (TTM)

12.85M

Free Cash Flow (TTM)

187.17M

Capital Expenditure (TTM)

-14.49M

Net Change in Cash (TTM)

215.88M

Analyst Trends and Forecast

2

Aug 25

1

Sep 25

1

Nov 25

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.22B

PE Ratio (TTM)

11.90

PE Ratio (FWD)

9.52

PEG Ratio (TTM)

0.27

PS Ratio (TTM)

4.59

PB Ratio (TTM)

1.46

Earnings Yield % (TTM)

8.40%

Earnings Yield % (FWD)

10.50%

EV / EBITDA (TTM)

5.99

Price / EBITDA (TTM)

8.89

Price / Free Cash Flow (TTM)

9.54

Book Value / Share

$13.51

Company Debt

Total Debt

$257.38M

LT Debt

$257.38M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$476.51M

Debt to Equity

0.26

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$25.00K

Key Statistics

Open

$19.69

Close

$20.00

Volume / Avg.

836.86K / 830.41K

Day Range

$19.58 - $20.15

52 Wk Range

16.52 - 22.76

Market Cap

$1.50B

P/E Ratio

11.90

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

10.46%

Days to Cover

5.57

About

Sector

Health Care

Industry

Pharmaceuticals

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering...

Show More

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Innoviva (INVA) stock?

A

You can purchase shares of Innoviva (NASDAQ:INVA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Innoviva (INVA) competitors?

A

Other companies in Innoviva’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), GH Research PLC (NASDAQ:GHRS), AtaiBeckley Inc (NASDAQ:ATAI), Xeris Biopharma Holdings Inc (NASDAQ:XERS) and Phibro Animal Health Corp (NASDAQ:PAHC).

Q

What is the forecast, or price target, for Innoviva (INVA) stock?

A

Innoviva has a consensus price target of $28.69.

Q

What is the current price for Innoviva (INVA)?

A

The stock price for Innoviva (NASDAQ: INVA) is $20.02 last updated January 30, 2026 at 5:31 PM EST.

Q

Does Innoviva (INVA) pay a dividend?

A

There are no upcoming dividends for Innoviva.

Q

When is Innoviva (NASDAQ:INVA) reporting earnings?

A

Innoviva does not have any upcoming earnings scheduled.

Q

Is Innoviva (INVA) going to split?

A

There is no upcoming split for Innoviva.

Q

What sector and industry does Innoviva (INVA) operate in?

A

Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Theravance Biopharma Inc

GH Research PLC

AtaiBeckley Inc

Xeris Biopharma Holdings Inc

Phibro Animal Health Corp

Rapport Therapeutics Inc

ANI Pharmaceuticals Inc

Phathom Pharmaceuticals Inc